30-Sep-23 | 30-Sep-22 | 30-Sep-21 | 30-Sep-20 | 30-Sep-19 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Americas | 82.70 | 27% | 94.50 | 28% | 77.40 | 25% | n/a | n/a | 89.40 | 30% |
Asia Pacific | n/a | n/a | n/a | n/a | 85.90 | 28% | n/a | n/a | 77.10 | 26% |
Asia-Pacific | 92.50 | 30% | 97.90 | 29% | n/a | n/a | n/a | n/a | n/a | n/a |
EMEA | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 123.50 | 42% |
Europe | n/a | n/a | n/a | n/a | 139.30 | 45% | n/a | n/a | n/a | n/a |
Europe, the Middle East and Africa | 127.60 | 42% | 144.30 | 42% | n/a | n/a | n/a | n/a | n/a | n/a |
UK | n/a | n/a | n/a | n/a | 3.70 | 1% | n/a | n/a | 4.00 | 1% |
United Kingdom | 4.20 | 1% | 4.30 | 1% | n/a | n/a | n/a | n/a | n/a | n/a |
Total | 307.00 | 100% | 341.00 | 100% | 306.30 | 100% | 266.00 | n/a | 294.00 | 100% |
Profit Before Tax | ||||||||||
Unanalysed | 72.50 | 100% | 87.70 | 100% | 92.50 | 100% | n/a | n/a | 104.70 | 100% |
Total | 72.50 | 100% | 87.70 | 100% | 92.50 | 100% | 63.50 | n/a | 104.70 | 100% |
30-Sep-23 | 30-Sep-22 | 30-Sep-21 | 30-Sep-20 | 30-Sep-19 | ||||||
---|---|---|---|---|---|---|---|---|---|---|
Revenue | ||||||||||
Industrial | n/a | n/a | n/a | n/a | 255.20 | 83% | n/a | n/a | 236.30 | 80% |
Medical | 65.20 | 21% | (3.10) | n/a | 51.10 | 17% | 49.70 | 19% | 57.70 | 20% |
Sustainable Solutions | 241.80 | 79% | 344.10 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Unanalysed | n/a | n/a | n/a | n/a | n/a | n/a | 216.30 | n/a | n/a | n/a |
Total | 307.00 | 100% | 341.00 | n/a | 306.30 | 100% | 266.00 | 100% | 294.00 | 100% |
Profit Before Tax | ||||||||||
Unanalysed | 72.50 | n/a | 87.70 | n/a | 92.50 | n/a | 63.50 | n/a | 104.70 | n/a |
Total | 72.50 | n/a | 87.70 | n/a | 92.50 | n/a | 63.50 | n/a | 104.70 | n/a |
You are here: research